483 Patheon Pharmaceuticals Mar 2016

483 Patheon Pharmaceuticals Mar 2016

Christopher Middendorf FDA, Lauren Smith FDA$119.00 - Available Now

FDA investigators audited the Patheon Pharmaceuticals - Cincinnati, OH, United States facility and issued inspectional observations (via FDA 483) on 11 Mar 2016.

Product details

  • Category: Human Drugs
  • Inspection end: 11 Mar 2016
  • Location: Cincinnati, United States
  • FEI: 1510437
Add To Cart